الفهرس 
Cataract and phacoemulsificationOnly 14 pages are availabe for public view
 |  | from | 188 |  |  |
| | | from | 188 | | |
Abstract
Background: Pseudophakic cystoid macuar edema (PCME) is an important cause of DROP of visual acuity after phacoemulsification especially in complicated cases, studies have focused on the ability of non-steroidal anti-inflammatory drops (NSAIDs) to prevent PCME.
Aim of study: This study aimed at evaluating the NSAIDs in prevention of PCME in phacoemulsification patients complicated by vitreous loss.
Patients and Methods: This study included 40 eyes of 40 patients complicated with vitreous loss, 20 of them received standard treatment and the other 20 received the standard treatment in addition to NSAIDs, each patient underwent assessment of BCVA and OCT macula scanning at 1st week and 1st month.
Results: This study found that NSAIDs attained better BCVA values when compared to patients who received the standard treatment only, they also recorded lower CMT thickness, however there were no significant difference between the 2 groups when patients with intraretinal cystoid changes were excluded.
Conclusion: At 1 month postoperative, patients who received NSAIDs had significantly better BCVA and did not develop intraretinal cysts.